113 related articles for article (PubMed ID: 24689682)
1. The LAN blood group system:a review.
Peyrard T
Immunohematology; 2013; 29(4):131-5. PubMed ID: 24689682
[TBL] [Abstract][Full Text] [Related]
2. Alleles of the LAN blood group system: molecular and serologic investigations.
Reid ME; Hue-Roye K; Huang A; Velliquette RW; Tani Y; Westhoff CM; Lomas-Francis C; Zelinski T
Transfusion; 2014 Feb; 54(2):398-404. PubMed ID: 23763549
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of immunized Jr(a-) or Lan- patients and validation of a high-throughput genotyping assay to screen blood donors for Jr(a-) and Lan- phenotypes.
Haer-Wigman L; Ait Soussan A; Ligthart P; de Haas M; van der Schoot CE
Transfusion; 2014 Jul; 54(7):1836-46. PubMed ID: 24456066
[TBL] [Abstract][Full Text] [Related]
4. The ABCB6 mutation p.Arg192Trp is a recessive mutation causing the Lan- blood type.
Saison C; Helias V; Peyrard T; Merad L; Cartron JP; Arnaud L
Vox Sang; 2013 Feb; 104(2):159-65. PubMed ID: 22958180
[TBL] [Abstract][Full Text] [Related]
5. ABCB6 is dispensable for erythropoiesis and specifies the new blood group system Langereis.
Helias V; Saison C; Ballif BA; Peyrard T; Takahashi J; Takahashi H; Tanaka M; Deybach JC; Puy H; Le Gall M; Sureau C; Pham BN; Le Pennec PY; Tani Y; Cartron JP; Arnaud L
Nat Genet; 2012 Jan; 44(2):170-3. PubMed ID: 22246506
[TBL] [Abstract][Full Text] [Related]
6. Erythrocytes lacking the Langereis blood group protein ABCB6 are resistant to the malaria parasite
Egan ES; Weekes MP; Kanjee U; Manzo J; Srinivasan A; Lomas-Francis C; Westhoff C; Takahashi J; Tanaka M; Watanabe S; Brugnara C; Gygi SP; Tani Y; Duraisingh MT
Commun Biol; 2018; 1():45. PubMed ID: 30271928
[TBL] [Abstract][Full Text] [Related]
7. Screening the expression of ABCB6 in erythrocytes reveals an unexpectedly high frequency of Lan mutations in healthy individuals.
Koszarska M; Kucsma N; Kiss K; Varady G; Gera M; Antalffy G; Andrikovics H; Tordai A; Studzian M; Strapagiel D; Pulaski L; Tani Y; Sarkadi B; Szakacs G
PLoS One; 2014; 9(10):e111590. PubMed ID: 25360778
[TBL] [Abstract][Full Text] [Related]
8. A review of the JR blood group system.
Castilho L; Reid ME
Immunohematology; 2013; 29(2):63-8. PubMed ID: 24094238
[TBL] [Abstract][Full Text] [Related]
9. The severity of hereditary porphyria is modulated by the porphyrin exporter and Lan antigen ABCB6.
Fukuda Y; Cheong PL; Lynch J; Brighton C; Frase S; Kargas V; Rampersaud E; Wang Y; Sankaran VG; Yu B; Ney PA; Weiss MJ; Vogel P; Bond PJ; Ford RC; Trent RJ; Schuetz JD
Nat Commun; 2016 Aug; 7():12353. PubMed ID: 27507172
[TBL] [Abstract][Full Text] [Related]
10. Hemolytic disease of the fetus and newborn caused by anti-Lan.
Brooks S; Squires JE
Transfusion; 2014 May; 54(5):1317-20. PubMed ID: 24188628
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of Lan antigen in Lan+, Lan+(w) and Lan- phenotypes.
McBean RS; Wilson B; Liew YW; Hyland CA; Flower RL
Blood Transfus; 2015 Oct; 13(4):662-5. PubMed ID: 25761317
[No Abstract] [Full Text] [Related]
12. Functional characterization of novel ABCB6 mutations and their clinical implications in familial pseudohyperkalemia.
Andolfo I; Russo R; Manna F; De Rosa G; Gambale A; Zouwail S; Detta N; Pardo CL; Alper SL; Brugnara C; Sharma AK; De Franceschi L; Iolascon A
Haematologica; 2016 Aug; 101(8):909-17. PubMed ID: 27151991
[TBL] [Abstract][Full Text] [Related]
13. Anti-Lan Antibodies: A Rare Etiology of Severe Blood Transfusion Reaction.
Sharma P; Manthri S; Patterson E; Youssef B; Chakraborty K
Cureus; 2020 Oct; 12(10):e10832. PubMed ID: 33173638
[TBL] [Abstract][Full Text] [Related]
14. Missense mutations in the ABCB6 transporter cause dominant familial pseudohyperkalemia.
Andolfo I; Alper SL; Delaunay J; Auriemma C; Russo R; Asci R; Esposito MR; Sharma AK; Shmukler BE; Brugnara C; De Franceschi L; Iolascon A
Am J Hematol; 2013 Jan; 88(1):66-72. PubMed ID: 23180570
[TBL] [Abstract][Full Text] [Related]
15. A new ABCG2 null allele with a 27-kb deletion including the promoter region causing the Jr(a-) phenotype.
Ogasawara K; Osabe T; Suzuki Y; Tsuneyama H; Isa K; Kawai M; Obara K; Ogiyama Y; Ito S; Uchikawa M; Satake M; Tadokoro K
Transfusion; 2015 Jun; 55(6 Pt 2):1467-71. PubMed ID: 25522810
[TBL] [Abstract][Full Text] [Related]
16. Raph blood group system.
Hayes M
Immunohematology; 2014; 30(1):6-10. PubMed ID: 25238243
[TBL] [Abstract][Full Text] [Related]
17. ABCB6, an ABC Transporter Impacting Drug Response and Disease.
Boswell-Casteel RC; Fukuda Y; Schuetz JD
AAPS J; 2017 Nov; 20(1):8. PubMed ID: 29192381
[TBL] [Abstract][Full Text] [Related]
18. Identification of a mammalian mitochondrial porphyrin transporter.
Krishnamurthy PC; Du G; Fukuda Y; Sun D; Sampath J; Mercer KE; Wang J; Sosa-Pineda B; Murti KG; Schuetz JD
Nature; 2006 Oct; 443(7111):586-9. PubMed ID: 17006453
[TBL] [Abstract][Full Text] [Related]
19. The rare red cell phenotype Lan negative in Japanese.
Okubo Y; Yamaguchi H; Seno T; Araki Y; Noguchi M; Shioda K; Takai M; Daniels GL
Transfusion; 1984; 24(6):534-5. PubMed ID: 6506188
[TBL] [Abstract][Full Text] [Related]
20. Role of the N-terminal transmembrane domain in the endo-lysosomal targeting and function of the human ABCB6 protein.
Kiss K; Kucsma N; Brozik A; Tusnady GE; Bergam P; van Niel G; Szakacs G
Biochem J; 2015 Apr; 467(1):127-39. PubMed ID: 25627919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
